Status:
COMPLETED
Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids
Lead Sponsor:
The University of Hong Kong
Conditions:
Leiomyoma
Eligibility:
All Genders
18-52 years
Phase:
PHASE3
Brief Summary
On the basis of empirical evidence and clinical practice, the investigators have developed a formula called Tumor-shrinking Decoction (TSD) used in the treatment of uterine fibroids (UFs). The investi...
Detailed Description
Numerous Chinese medicine preparations have been shown to possess therapeutic potential in relieving uterine fibroids (UFs) symptoms and shrinking the volume of fibroids without significant adverse ef...
Eligibility Criteria
Inclusion
- Premenopausal women aged 18 to 52 years; and
- have a primary diagnosis of symptomatic UFs based on clinical symptoms; and
- MRI examination as defined in the International Classification of Diseases (10th edition).
Exclusion
- Unstable medical conditions such as serious cardiovascular diseases;
- With severe neuropsychiatric disorders;
- Combined with adenomyosis or other tumors;
- On treatment with Chinese medicine or other natural products in the previous 3 months;
- With an allergic history of herbal medicine; or
- Being pregnant and lactating women and those who currently use contraception.
Key Trial Info
Start Date :
May 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT02189083
Start Date
May 1 2014
End Date
February 1 2016
Last Update
October 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Chinese Medicine, University of Hong Kong
Hong Kong, China, 852